Researchers identify what drives PARP inhibitor resistance in advanced breast cancer 08 May 2024 Researchers at The Institute of Cancer Research, London, have increased our understanding of how a cancer drug called a PARP inhibitor stops working in women with breast cancer that has spread. This research could ultimately help predict who’s more likely to respond to these drugs, and could lead to more effective ways to treat the disease. Find out more Show/Hide
Scientists uncover promising new treatment strategy for aggressive form of leukaemia 18 Apr 2024 Scientists have uncovered a promising treatment strategy for an aggressive type of leukaemia – through targeting the enzymes that cells normally use to sense and adapt to changing oxygen levels. Find out more Show/Hide
Shape-shifting cancer cell discovery reveals two potential drug targets against skin cancer 17 Apr 2024 Scientists have discovered how skin cancer cells shapeshift based on their environment – enabling them to spread through the body and cause a metastatic cancer. Find out more Show/Hide
New technique opens up study of immune response to cancer by releasing precious material locked in old archive cancer samples 14 Mar 2024
ICR scientists seek new drugs to treat childhood cancer as part of global Cancer Grand Challenges team 06 Mar 2024
Major collaborative childhood cancer research programme launched with £5.5 million funding from Children with Cancer UK and Cancer Research UK 20 Nov 2023
Scientists reverse drug resistance in prostate cancer by targeting 'hijacked' white blood cells 16 Oct 2023
Deliberately damaging DNA could boost the effectiveness of immunotherapy in kidney cancer 20 Sep 2022